Results 1 to 10 of about 271,748 (386)

EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update

open access: yesAnnals of the Rheumatic Diseases, 2023
Background Since the publication of the EULAR recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several randomised clinical trials have been published that have the potential to change ...
B. Hellmich   +26 more
semanticscholar   +1 more source

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

open access: yesArthritis care & research, 2021
To provide evidence‐based recommendations and expert guidance for the management of antineutrophil cytoplasmic antibody–associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic ...
Sharon A. Chung   +31 more
semanticscholar   +2 more sources

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis

open access: yesArthritis & Rheumatology, 2021
To provide evidence‐based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel vasculitis.
M. Maz   +31 more
semanticscholar   +1 more source

Avacopan for the treatment of ANCA-associated vasculitis

open access: yesExpert Review of Clinical Immunology, 2021
Introduction: Anti-neutrophil cytoplasm autoantibodies (ANCA)-associated vasculitides (AAVs) are a group of rare heterogeneous diseases characterized by blood vessel inflammation resulting in organ destruction and death.
M. Osman   +2 more
semanticscholar   +2 more sources

Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders

open access: yesBMC Women's Health, 2021
Background Consequences of long-term B cell depletion with rituximab are not well understood. We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment, distinct from previously described vulvovaginal pyoderma ...
Laura Yockey   +8 more
doaj   +1 more source

Global epidemiology of vasculitis

open access: yesNature Reviews Rheumatology, 2021
The many forms of vasculitis are characterized by inflammation of blood vessels, leading to potentially long-term sequelae including vision loss, aneurysm formation and kidney failure. Accurate estimation of the incidence and prevalence has been hampered
R. Watts   +3 more
semanticscholar   +1 more source

A sore red eye with systemic involvement [PDF]

open access: yes, 2012
The study of happiness has long been a playground for philosophical speculation. By lack of empirical measures of happiness, it was not possible to check propositions about the matter.
Lightman, SL   +3 more
core   +2 more sources

Diagnostic delays in vasculitis and factors associated with time to diagnosis

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Patients with vasculitis, a set of rare diseases, encounter delays in obtaining an accurate diagnosis which can lead to substantial morbidity and increased mortality.
Antoine G. Sreih   +9 more
doaj   +1 more source

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol

open access: yesTrials, 2023
Background Sequential B cell-targeted immunotherapy with BAFF antagonism (belimumab) and B cell depletion (rituximab) may enhance B cell targeting in ANCA-associated vasculitis (AAV) through several mechanisms.
Mark E. McClure   +13 more
doaj   +1 more source

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.

open access: yesNew England Journal of Medicine, 2020
BACKGROUND More effective and safer treatments are needed for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. METHODS We conducted a randomized trial with a 2-by-2 factorial design to evaluate the use of plasma exchange and two ...
M. Walsh   +34 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy